Beam Therapeutics Inc
NASDAQ:BEAM 3:59:53 PM EDT
Products
Beam Therapeutics Announces FDA Clinical Hold On BEAM-201 IND Application
Published: 08/01/2022 12:02 GMT
Beam Therapeutics Inc (BEAM) - Beam Therapeutics Announces FDA Clinical Hold on Beam-201 Ind Application.
Beam Therapeutics Inc - FDA Indicated They Will Provide an Official Clinical Hold Letter to Beam Within 30 Days.
Beam Therapeutics Inc - Beam Plans to Provide Additional Updates Pending Discussion With FDA.
Beam Therapeutics Inc - FDA Indicated They Will Provide an Official Clinical Hold Letter to Beam Within 30 Days.
Beam Therapeutics Inc - Beam Plans to Provide Additional Updates Pending Discussion With FDA.